Healthcare - Biotechnology - NASDAQ - US
$ 13.31
-7.05 %
$ 1.34 B
Market Cap
-13.72
P/E
Price Target
Average
166.18%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
28.30%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Day One Biopharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for DAWN of $35.4 , with forecasts ranging from a low of $24 to a high of $45 .
DAWN Lowest Price Target
Wall Street Target
24 USD
80.32%
DAWN Average Price Target
Wall Street Target
35.4 USD
166.18%
DAWN Highest Price Target
Wall Street Target
45 USD
238.09%
REVENUE FORECAST
Revenue Forecast Chart DAWN
EBIT FORECAST
EBIT Forecast Chart DAWN
NET INCOME FORECAST
Net Income Chart DAWN